Epiploic appendagitis is a relatively rare, benign condition of the colon that can be easily misdiagnosed due to its vague symptoms. It is caused by inflammation of the epiploic appendages, small fatty appendages that are attached to the outer wall of the colon. The condition is often misdiagnosed as diverticulitis, appendicitis, or even colorectal cancer. It is important for doctors to be aware of the condition in order to properly diagnose and treat it.
The most common symptom of epiploic appendagitis is abdominal pain, which is usually localized to the left lower quadrant. Other symptoms can include nausea, vomiting, constipation, and fever. The pain is usually sharp and can radiate to the back or groin area. It can also be worse when the patient is lying down or when they press on the area.
The diagnosis of epiploic appendagitis is usually made through a combination of physical examination, imaging tests, and laboratory tests. Physical examination often reveals tenderness to palpation in the left lower quadrant. Imaging tests such as CT scans, MRIs, and ultrasounds can help to confirm the diagnosis by showing the presence of inflamed epiploic appendages. Laboratory tests, such as blood tests, can be used to rule out other conditions.
The treatment of epiploic appendagitis is usually conservative. Treatment typically involves bed rest, pain medications, and antibiotics. Surgery is rarely necessary, although it may be recommended if the condition does not respond to conservative treatments. In most cases, the condition resolves on its own within a few weeks.
Although epiploic appendagitis is usually a benign condition, there are some potential complications that can occur. These include abscess formation, perforation of the colon, and obstruction of the colon. It is important for doctors to be aware of these potential complications in order to provide the best possible care for their patients.
Epiploic appendagitis is a relatively rare condition of the colon that can be easily misdiagnosed due to its vague symptoms. It is important for doctors to be aware of the condition in order to properly diagnose and treat it. Treatment is usually conservative and involves bed rest, pain medications, and antibiotics. Surgery is rarely necessary, although it may be recommended if the condition does not respond to conservative treatments. In most cases, the condition resolves on its own within a few weeks. However, it is important for doctors to be aware of the potential complications that can occur in order to provide the best possible care for their patients.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation